We serve Chemical Name:Serinamide CAS:25739-59-7 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name:Serinamide
CAS.NO:25739-59-7
Synonyms:Hydroxy-2-amino-3-phenazin;DL-serine amide;3-Amino-2-phenazinol;DL-Serinamid;3-amino-phenazin-2-ol;2-aminophenazin-3-ol;2-Phenazinol,3-amino;2-Amino-3-hydroxy-phenazin;serine amide;2-amino-3-hydroxy-phenazine;2-amino-3-hydroxy-propionamide;DL-2-Amino-3-hydroxy-propionsaeure-amid
Molecular Formula:C3H8N2O2
Molecular Weight:104.10800
HS Code:2924199090
Physical and Chemical Properties:
Melting point:N/A
Boiling point:N/A
Density:N/A
Index of Refraction:
PSA:90.33000
Exact Mass:104.05900
LogP:
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:
Contact us for information like Hydroxy-2-amino-3-phenazin chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,DL-2-Amino-3-hydroxy-propionsaeure-amid physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,2-Phenazinol,3-amino Use and application,2-amino-3-hydroxy-phenazine technical grade,usp/ep/jp grade.
Related News: When using the raw materials, as an API manufacturer we produce API in the large reactor in our plant. Serinamide manufacturer ��We are very worried,�� Chuang Shuk-kwan, a health official, said at a news conference on Sunday. ��Everyone should prepare mentally for the possibility that the disease is spreading within the community.�� Serinamide supplier The injection has previously proven to be as effective as standard daily pills with three active ingredients when administered monthly and also once every two months. Serinamide vendor Also, the study did not compare people who had COVID-19 with those who did not, to see if such symptoms were higher than in the general population. The report did exclude patients with certain serious or chronic preexisting conditions like cancer, kidney disease, HIV, liver disease and stroke, to separate their previous health status from post-COVID symptoms. Serinamide factory Rigosertib is a small molecule that inhibits cellular signaling in cancer cells by acting as a RAS mimetic. Current clinical development of rigosertib is centered upon the therapeutic management of MDS, a heterogeneous group of bone marrow disorders characterized by ineffective hematopoiesis that often develop into acute myeloid leukaemia (AML).
